Tris Pharma
Steve Waundless is a Senior Healthcare Sales Professional at Tris Pharma since April 2019, focusing on promoting products for patients with Attention Deficit/Hyperactivity Disorder (ADHD). Notable achievements include ranking as the #1 representative in the Midwest Region in Q2 2022 and being selected as a member of the Tris Marketing Field Advisory Board in 2020. Previous roles include Professional Sales Representative at Publicis Touchpoint Solutions, where the focus was on novel therapies for ADHD, and Senior Account Manager at Premier Commercial Services, managing collaborations for commercial and medical workspace solutions. Waundless also has extensive experience from Shire, where roles included Senior Executive Sales Specialist and ADHD Patient Advocacy Specialist, contributing to increased awareness and utilization of CNS medications. Waundless holds a Bachelor of Arts degree from Wayne State University.
This person is not in any offices
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.